Hepatology - European Medical Journal

Continue

Hepatology

Filter
EMJ 5.1
9 Mins
31 Mar 2020

Preparing Patients for Intervention: Interviews with Key Opinion Leaders in Hepatology and Interventional Radiology

For this article, EMJ conducted interviews with two key opinion leaders, Prof Edoardo G. Giannini and Dr Sachin Modi, world experts in hepatology…
4 Mins
24 Feb 2020

New Data on Aramchol TM for the Treatment of Non-alcoholic Steatohepatitis: Exploring Potential for Greater Efficacy and the Effect on Glucose Metabolism

Aramchol is a liver-targeted, oral stearoyl coenzyme A desaturase 1 (SCD1) modulator that has been shown to reduce liver fat and fibrosis in patients…
12 Mins
12 Dec 2019

A Review of Liver Fibrosis and Emerging Therapies

With the increasing burden of liver cirrhosis, the most advanced stage of hepatic fibrosis, there is a need to better understand the pathological…
9 Mins
6 Nov 2019

Hepatitis B Care Pathway in the United Arab Emirates: Current Situation, Gaps, and Actions

This paper aims to assess the current situation of the HBV care pathway in the United Arab Emirates (UAE), identify gaps and barriers therein…
6 Mins
12 Sep 2019

Noninvasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?

New imaging modalities are emerging and may potentially replace biopsy. This review discusses the different noninvasive imaging modalities…
12 Mins
12 Sep 2019

Cholestasis in the Baby and Infant

Cholestasis is seen in every 2,500–5,000 live births. In full-term infants, jaundice that lasts >2 weeks should be evaluated; however, it should be…
11 Mins
12 Sep 2019

Primary Sclerosing Cholangitis: A Clinical Update

Primary sclerosing cholangitis (PSC) is a rare cholestatic disorder of the liver associated with inflammation and injury with fibrosis in the…
3 Mins
28 May 2019

Transjugular Intrahepatic Portosystemic Stent-Shunt (TIPSS) for Acute Variceal Bleeding: Has it Come of Age?

Despite the introduction of covered TIPSS, studies have not consistently demonstrated a survival benefit in secondary prevention…